Artificial Intelligence in the Pharmaceutical market worth US$27,156.1 Million in 2031. Visiongain Research Inc.

Visiongain has published a new report on "AI in Pharmaceuticals Market 2021-2031". Embracing Technology to Revolutionize Pharmaceutical Industry There are other fields where the R&D process can be influenced by AI and machine learning. Better approaches to predict chemicals' properties in order to reduce the number of substances that need to be synthesized is obviously an opportunity. This would allow for the consideration of a larger chemical universe and enrich the'chemical palette' open to medicinal chemists. Another field where researchers are starting to use AI and machine learning is mining genomic, proteomic, and metabolic data for improved disease biomarkers and medication efficacy surrogate markers.